Human cervical cancer HeLa cells and human embryonic kidney (HEK) 293 T cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% fetal bovine serum (FBS). For the luciferase assay, HEK293T cells (105) were transfected with 1 μg pCAGIG-V5 vectors encoding Vax1, Vax1AA, or Vax1(R152S) cDNA together with pGL3-Tcf7l2-luciferase (0.2 μg) and pCMV-β-gal (0.2 μg) reporter constructs. Luciferase activity in the transfected cells was measured at 24 h posttransfection and normalized to β-galactosidase activity to obtain the relative luciferase activity of the cells. To test the cellular penetration of the Vax1 protein, V5 peptides or V5-Vax1 proteins, which were purified from HEK293T cells, were added to the growth media (1.5 pmol/ml [final concentration]) of HeLa cells, which express GFP-Sdc2. The distribution of V5 peptides and V5-Vax1 proteins on the cell surface and inside the cells was examined by immunostaining with mouse anti-V5 and chicken anti-GFP antibodies.
Retinal explants were prepared as described previously16 . Briefly, the retina was prepared from mouse embryos at E13 and mixed with collagen in DMEM supplemented with 10% FBS. The retinal explants in collagen were then cultured in neurobasal medium containing B27 supplement (Invitrogen Inc.) for 48 h to allow the axons to grow from the explants. 6X-Histidine peptides or Vax1-6X-His proteins, which were purified from E. coli, were then added to the culture medium (2 pmol/ml [final concentration]) of retinal explants. Alternatively, the retinal explants were placed next to collagen droplets containing HEK293 cells (105 cells/droplet), which express Vax1 or Vax1AA. The lengths of retinal axons grown from the explants were measured before and after the treatments to determine the axon growth rate.
Free full text: Click here